1. Home
  2. XENE vs HWKN Comparison

XENE vs HWKN Comparison

Compare XENE & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$43.73

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$145.49

Market Cap

2.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
XENE
HWKN
Founded
1996
1938
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.7B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
XENE
HWKN
Price
$43.73
$145.49
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
$53.91
$200.00
AVG Volume (30 Days)
793.2K
158.0K
Earning Date
11-03-2025
01-28-2026
Dividend Yield
N/A
0.53%
EPS Growth
N/A
1.59
EPS
N/A
3.97
Revenue
$7,500,000.00
$1,045,229,000.00
Revenue This Year
N/A
$14.63
Revenue Next Year
N/A
$7.07
P/E Ratio
N/A
$35.84
Revenue Growth
N/A
11.86
52 Week Low
$26.74
$98.30
52 Week High
$46.60
$186.15

Technical Indicators

Market Signals
Indicator
XENE
HWKN
Relative Strength Index (RSI) 56.88 63.19
Support Level $42.89 $137.94
Resistance Level $44.57 $139.00
Average True Range (ATR) 1.42 3.94
MACD -0.07 2.47
Stochastic Oscillator 33.10 96.94

Price Performance

Historical Comparison
XENE
HWKN

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

Share on Social Networks: